The 34th PALAS SciCon has been approved for 12 (Chemistry), 7 (Pharmacy), 8 (Medicine), and 7 (Veterinary Medicine) CPD Points
Dr. Rohani B. Cena-Navarro is a Principal Investigator at the Behavioral Neuroscience Laboratory, National Institutes of Health, UP Manila, dedicated to addressing substance use addiction. In her presentation, "Using a Rodent Model to Evaluate Low-Cost Treatments for Inhalant Addiction in the Philippines," Dr. Cena-Navarro will discuss innovative research aimed at combating inhalant addiction, a significant issue in the Philippines. By utilizing rodent models, her work evaluated the efficacy of affordable, accessible treatment options for those suffering from this addiction. Dr. Cena-Navarro’s research seeks to provide evidence-based, cost-effective solutions that can be adapted to local contexts, ultimately improving addiction treatment strategies and public health outcomes.
Using a Rodent Model to Evaluate Low-Cost Treatments for Inhalant Addiction in the Philippines
BACKGROUND
The use of solvents (toluene) is a worldwide problem and is prevalent especially in Filipino street boys and girls. Despite years of research, important questions have not been addressed and treatments have not been successful. Studies on the effects of toluene on female and social behavior are also unknown. We recently reported that repeated toluene inhalation at 3000 ppm increased conditioned place preference (CPP) in females and impaired social novelty preference during the abstinence period (Asis et al., 2024).
OBJECTIVES
We now attempt to restore these behavioral deficits using low-cost pharmacological (N-acetylcysteine) and behavioral (exercise) treatments. NAC and exercise are two treatments that have been shown to decrease drug-seeking in other substance abuse but have not been tested in toluene.
METHODS
We repeatedly exposed adolescent male and female Sprague Dawley rats to toluene vapor (3000 ppm) for six days using the CPP paradigm. During an eight-day abstinence period, animals received either N-acetylcysteine (100 mg/kg, intraperitoneally) or daily voluntary wheel running (4 hours/day) as low-cost interventions. We assessed drug-associated context preference, locomotor activity, and social preference throughout the abstinence period.
RESULTS
Here, we report that daily NAC injections (100 mg/kg I.P.) during abstinence (D1 to D8) significantly decreased the CPP score (two-way RM ANOVA main effect of time: p=0.001) in toluene-exposed males. In toluene-exposed females that received treatments via drinking water, NAC significantly decreased the CPP score (two-way RM ANOVA main effect of time: p=0.007). Similar to NAC, exercise using daily voluntary wheel running (4h/d) during abstinence (D1 to D8) significantly reduced CPP score in toluene-exposed rats (two-way RM ANOVA time × group interaction: p=0.037). NAC and exercise also restored social novelty preference in females (NAC: two-way RM ANOVA main effect of time p=0.026; Exercise: two-way RM ANOVA main effect of phase: p=0.022). Lastly, exercise (but not NAC) reduced locomotion in females (t-test p=0.006), but not in males (t-test p=0.156).
CONCLUSIONS
Overall, NAC and exercise treatment can reverse the toluene-induced behavioral deficits during the abstinence period. We are now performing cFos immunofluorescence to determine the extent of treatments in reversing the brain back to its pre-addiction state.